Symrise Q1 Earnings Call Highlights

3 weeks ago 13

MarketBeat

Wed, April 29, 2026 astatine 7:37 AM CDT 7 min read

Symrise logo

Key Points

Symrise said Q1 came successful “ahead of expectations” with integrated income down -0.4% year‑over‑year; show was mixed by segment—Taste, Nutrition & Health +1.7% versus Scent & Care -3.4%—and regionally North America, Latin America and Asia grew portion EMEA -4.9% weighed connected the group.
The institution is accelerating its ONE SYM transformation, having delivered astir EUR 100m of cumulative savings and ~280 bps of borderline enlargement since 2023, portion expanding capableness (new pet‑food tract successful Querétaro) and taking a involvement successful Bond Pet Foods to enactment innovation and sustainable macromolecule exposure.
Management plans terms increases and surcharges to offset rising freight/logistics and raw‑material costs, and reiterated full‑year 2026 guidance of 2%–4% integrated growth, adjusted EBITDA borderline 21.5%–22.5%, and midterm targets of 5%–7% integrated maturation (2025–2028).
Interested successful Symrise AG? Here are 5 stocks we similar better.

Symrise (ETR:SY1) reported a first-quarter 2026 show that absorption said came successful “ahead of expectations,” arsenic the institution navigated a anemic macroeconomic backdrop, hard year-ago comparisons, and emerging input-cost uncertainty tied mostly to freight and logistics.

On the company’s Q1 2026 trading connection call, CEO Jean-Yves Parisot said the radical posted an integrated income diminution of 0.4% twelvemonth implicit year, compared with what the institution had expected coming into the year. He attributed resilience to portfolio equilibrium and execution, portion emphasizing that Symrise is accelerating its ONE SYM translation to money reinvestment successful growth.

Q1 sales: humble integrated diminution with mixed conception show

→ Pipelines and Automation: 2 Energy Plays Built for Any Oil Price

Parisot said Q1 income were “stronger than anticipated,” driven by nutrient and beverage, pet-related business, and fragrance, with “strong momentum towards the extremity of the quarter.” At the radical level, Symrise reported integrated income down 0.4%, comprised of 0.3% affirmative volumes and a 0.7% antagonistic pricing contribution. Foreign speech was described arsenic a headwind, which absorption attributed mostly to the stronger U.S. dollar successful 2025.

By segment, the institution outlined a divided picture:

Taste, Nutrition & Health: integrated income +1.7%, with measurement up 1% and pricing up 0.7%. Parisot cited continued spot successful nutrient and beverage, with Naturals and Savory delivering mid-single-digit maturation and beverages increasing debased azygous digits. Pet Food grew debased azygous digits, with debased single-digit maturation successful palatability and a flimsy diminution successful favored nutrition owed to terms normalization contempt affirmative volumes.
Scent & Care: integrated income -3.4%, driven by antagonistic pricing of -2.7% and volumes down -0.7%. Fragrance grew debased azygous digits against beardown comparables, supported by mid-single-digit user fragrance maturation and debased single-digit good fragrance growth. Care and Wellness declined “low treble digits,” which absorption chiefly attributed to a double-digit alteration successful UV filters against an elevated prior-year base. Aroma Molecules declined “mid-single digits” connected pugnacious comparables, portion specialty fragrance ingredients performed well.